LOS ANGELES, Jan. 30, 2026 (GLOBE NEWSWIRE) -- Glancy Prongay Wolke & Rotter LLP reminds investors of the upcoming March 9, 2026 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Ardent Health, Inc. (“Ardent” or the “Company”) (NYSE: ARDT) securities between July 18, 2024 and November 12, 2025, inclusive (the “Class Period”).

image for news Deadline Alert: Ardent Health, Inc. (ARDT) Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud Lawsuit

On Wednesday, the U.S. Food and Drug Administration (FDA) approved Tenpoint Therapeutics Ltd.'s Yuvezzi (carbachol and brimonidine tartrate ophthalmic solution) 2.75%/0.1%, previously known as Brimochol PF, the first and only dual-agent eye drop for presbyopia in adults.

image for news New FDA-Approved Eye Drop Sparks Fresh Competition For LENZ Therapeutics' Drug

Lululemon price target slashed on outgoing CEO's final day — Negative

LULU   Proactive Investors — January 30, 2026

Jefferies analysts lowered their price target on Lululemon Athletica Inc (NASDAQ:LULU) stock to $185 from $200, coinciding with the outgoing CEO Calvin McDonald's final day at the company. Shares of Lululemon traded at about $174 on Friday, down almost 60% in the last 12 months.

image for news Lululemon price target slashed on outgoing CEO's final day

Can Operational Execution Support DaVita's Q4 Performance? — Positive

DVA   Zacks Investment Research — January 30, 2026

DVA's fourth-quarter 2025 performance is likely to have gained from technology upgrades, cost control and seasonal boosts despite ongoing volume headwinds.

image for news Can Operational Execution Support DaVita's Q4 Performance?

CMCSA Q4 Earnings Beat On Theme Parks and Peacock Strength — Positive

CMCSA   Zacks Investment Research — January 30, 2026

Comcast tops Q4 EPS and revenues as Theme Parks and Peacock surge, offset by broadband losses, weaker Studios results and margin pressure.

image for news CMCSA Q4 Earnings Beat On Theme Parks and Peacock Strength

Schneider Q4 Earnings Miss Estimates, Down Year Over Year — Negative

SNDR   Zacks Investment Research — January 30, 2026

SNDR reports Q4 earnings miss as softer demand and higher costs weigh on results. It expects its 2026 EPS to be in the range of 70 cents-$1.00.

image for news Schneider Q4 Earnings Miss Estimates, Down Year Over Year

All You Need to Know About 1st Source (SRCE) Rating Upgrade to Buy — Positive

SRCE   Zacks Investment Research — January 30, 2026

1st Source (SRCE) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

image for news All You Need to Know About 1st Source (SRCE) Rating Upgrade to Buy

WisdomTree, Inc. (WT) Reports Q4 Earnings: What Key Metrics Have to Say — Positive

WT   Zacks Investment Research — January 30, 2026

The headline numbers for WisdomTree, Inc. (WT) give insight into how the company performed in the quarter ended December 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

image for news WisdomTree, Inc. (WT) Reports Q4 Earnings: What Key Metrics Have to Say

Innovex International (INVX) is a Great Momentum Stock: Should You Buy? — Positive

INVX   Zacks Investment Research — January 30, 2026

Does Innovex International (INVX) have what it takes to be a top stock pick for momentum investors? Let's find out.

image for news Innovex International (INVX) is a Great Momentum Stock: Should You Buy?

Oceaneering International (OII) Upgraded to Strong Buy: What Does It Mean for the Stock? — Positive

OII   Zacks Investment Research — January 30, 2026

Oceaneering International (OII) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

image for news Oceaneering International (OII) Upgraded to Strong Buy: What Does It Mean for the Stock?

Brookfield Renewable (BEP) Reports Q4 Earnings: What Key Metrics Have to Say — Neutral

BEP   Zacks Investment Research — January 30, 2026

While the top- and bottom-line numbers for Brookfield Renewable (BEP) give a sense of how the business performed in the quarter ended December 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

image for news Brookfield Renewable (BEP) Reports Q4 Earnings: What Key Metrics Have to Say

SQM (SQM) Is Up 10.19% in One Week: What You Should Know — Positive

SQM   Zacks Investment Research — January 30, 2026

Does SQM (SQM) have what it takes to be a top stock pick for momentum investors? Let's find out.

image for news SQM (SQM) Is Up 10.19% in One Week: What You Should Know

All You Need to Know About Trupanion (TRUP) Rating Upgrade to Strong Buy — Positive

TRUP   Zacks Investment Research — January 30, 2026

Trupanion (TRUP) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

image for news All You Need to Know About Trupanion (TRUP) Rating Upgrade to Strong Buy

Sibanye Gold Limited (SBSW) is a Great Momentum Stock: Should You Buy? — Positive

SBSW   Zacks Investment Research — January 30, 2026

Does Sibanye Gold Limited (SBSW) have what it takes to be a top stock pick for momentum investors? Let's find out.

image for news Sibanye Gold Limited (SBSW) is a Great Momentum Stock: Should You Buy?

What Makes Cabaletta Bio, Inc. (CABA) a Strong Momentum Stock: Buy Now? — Positive

CABA   Zacks Investment Research — January 30, 2026

Does Cabaletta Bio, Inc. (CABA) have what it takes to be a top stock pick for momentum investors? Let's find out.

image for news What Makes Cabaletta Bio, Inc. (CABA) a Strong Momentum Stock: Buy Now?

QCR Holdings (QCRH) Upgraded to Buy: What Does It Mean for the Stock? — Positive

QCRH   Zacks Investment Research — January 30, 2026

QCR Holdings (QCRH) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

image for news QCR Holdings (QCRH) Upgraded to Buy: What Does It Mean for the Stock?

Sana Biotechnology (SANA) Is Up 5.46% in One Week: What You Should Know — Positive

SANA   Zacks Investment Research — January 30, 2026

Does Sana Biotechnology (SANA) have what it takes to be a top stock pick for momentum investors? Let's find out.

image for news Sana Biotechnology (SANA) Is Up 5.46% in One Week: What You Should Know

Monday.com (MNDY) Upgraded to Buy: Here's Why — Positive

MNDY   Zacks Investment Research — January 30, 2026

Monday.com (MNDY) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

image for news Monday.com (MNDY) Upgraded to Buy: Here's Why

Adtalem (ATGE) Upgraded to Buy: Here's What You Should Know — Positive

ATGE   Zacks Investment Research — January 30, 2026

Adtalem (ATGE) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

image for news Adtalem (ATGE) Upgraded to Buy: Here's What You Should Know

Avidbank Holdings, Inc. (AVBH) Q4 2025 Earnings Call Transcript — Neutral

AVBH   Seeking Alpha — January 30, 2026

Avidbank Holdings, Inc. (AVBH) Q4 2025 Earnings Call Transcript

image for news Avidbank Holdings, Inc. (AVBH) Q4 2025 Earnings Call Transcript